Litcius/Paper detail

COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a++

Moritz Anft, Krystallenia Paniskaki, Arturo Blazquez‐Navarro, Adrian Doevelaar, Felix S. Seibert, Bodo Hölzer, Sarah Skrzypczyk, Eva Kohut, Julia Kurek, Jan Zapka, Patrizia Wehler, Sviatlana Kaliszczyk, Sharon Bajda, Constantin J. Thieme, Toralf Roch, Margarethe Konik, Marc Moritz Berger, Thorsten Brenner, Uwe Kölsch, Toni Luise Meister, Stephanie Pfaender, Eike Steinmann, Clemens Tempfer, Carsten Watzl, Sebastian Dolff, Ulf Dittmer, Mohamed Abou‐El‐Enein, Timm H. Westhoff, Oliver Witzke, Ulrik Stervbo, Nina Babel

2020Molecular Therapy43 citationsDOIOpen Access PDF

Topics & Concepts

ARDSCD8ImmunologyFlow cytometryEffectorImmune systemT cellCD11aMemory T cellMedicineBiologyLungInternal medicineIntegrin alpha MCD18COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research
COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a++ | Litcius